Release Date: 23/05/12 19:07 Summary: Amended Change of Director's Interest Notice - Appendix 3Y's Price Sensitive: No Download Document 234.12KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%